Arcadia Biosciences, Inc. Balance Sheet
RKDA|11 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
Arcadia Biosciences, Inc. had $7M in total assets and $6M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $259.0K | $4.2M | $6.5M | $20.6M | $28.7M | $14.0M | $8.4M | $9.1M | $2.0M | $24.0M | $16.6M |
| Accounts Receivable | - | - | - | - | $1.4M | $1.4M | $602.0K | $165.0K | $1.2M | $349.0K | $706.0K |
| Inventory | $1.2M | $904.0K | $2.0M | $2.6M | $4.4M | $3.8M | $1.8M | $181.0K | $229.0K | $252.0K | $294.0K |
| Current Assets | $6.4M | $9.2M | $15.0M | $25.4M | $35.4M | $31.7M | $28.4M | $22.9M | $15.0M | $52.2M | $52.0M |
| PP&E (Net) | $8.0K | $41.0K | $384.0K | $704.0K | $2.3M | $3.5M | $1.8M | $395.0K | $299.0K | $508.0K | $585.0K |
| Goodwill | - | - | - | - | - | $408.0K | - | - | - | - | - |
| Total Assets | $6.5M | $13.5M | $19.7M | $28.9M | $43.9M | $47.3M | $32.6M | $24.0M | $16.6M | $56.6M | $74.2M |
| Current Liabilities | $2.1M | $2.6M | $3.6M | $4.2M | $5.0M | $6.3M | $5.7M | $3.1M | $3.5M | $3.1M | $3.5M |
| Total Debt | - | - | - | - | - | $2.1M | - | - | $0 | $25.1M | $24.9M |
| Shareholders' Equity | $6.2M | $12.7M | $12.8M | $21.0M | $31.1M | $27.7M | $7.7M | $8.0M | $22.2M | $40.2M | -$84.8M |